The well-established healthcare infrastructure and widespread access to advanced medications like Semaglutide and Tirzepatide facilitated rapid adoption
Funding cadence has a direct impact on whether employees actually use their benefit
Last reviewed: July 2, 2026 Last updated: July 2, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
For patients who prefer not to use injections or have difficulty with self-injection, this may be an alternative delivery option when prescribed
Our comprehensive approach includes expert guidance, nutritional counseling, and ongoing support